Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Pacific Biosciences of California, Inc. v. Oxford Nanopore Technologies, Inc.
Case Number:
1:17-cv-01353
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
March 18, 2020
Del. Jurors Clear Oxford Nanopore In DNA Tech Patent Suit
A federal jury in Delaware cleared Oxford Nanopore Technologies Inc. on Wednesday of claims that some of its DNA analysis technology and devices — used in early coronavirus investigations in China — infringed four patents held by Pacific Biosciences of California Inc.
-
March 09, 2020
Patent Trial Opens Over DNA Tool Used To ID Coronavirus
An attorney for developers of a DNA tool recently used to track the coronavirus in China told jurors in a federal patent trial in Delaware on Monday that Pacific Biosciences is using invalid infringement claims to derail competition in an important field of science.
-
April 25, 2019
PacBio DNA Patent Suit Survives Dismissal Push
A Delaware federal judge has refused to let Oxford Nanopore Technologies Ltd. escape an infringement suit from Pacific Biosciences over DNA sequencing patents, finding the U.K.-based company's effort at dismissal ignored a host of accusations that were "specific" to Oxford Ltd.
-
March 26, 2018
PacBio DNA Patent Survives Eligibility Challenge, Judge Finds
A Delaware federal judge has refused to dismiss infringement allegations brought by Pacific Biosciences against Oxford Nanopore over a DNA sequencing patent, rejecting Oxford's argument that the patent's claims covered an abstract concept or natural phenomenon ineligible for protection under the U.S. Supreme Court's Alice standard.